Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Activity‐based probes for the ubiquitin conjugation–deconjugation machinery: new chemistries, new tools, and new insights

Identifieur interne : 000769 ( Pmc/Checkpoint ); précédent : 000768; suivant : 000770

Activity‐based probes for the ubiquitin conjugation–deconjugation machinery: new chemistries, new tools, and new insights

Auteurs : David S. Hewings ; John A. Flygare ; Matthew Bogyo ; Ingrid E. Wertz

Source :

RBID : PMC:7163952

Abstract

The reversible post‐translational modification of proteins by ubiquitin and ubiquitin‐like proteins regulates almost all cellular processes, by affecting protein degradation, localization, and complex formation. Deubiquitinases (DUBs) are proteases that remove ubiquitin modifications or cleave ubiquitin chains. Most DUBs are cysteine proteases, which makes them well suited for study by activity‐based probes. These DUB probes report on deubiquitinase activity by reacting covalently with the active site in an enzyme‐catalyzed manner. They have proven to be important tools to study DUB selectivity and proteolytic activity in different settings, to identify novel DUBs, and to characterize deubiquitinase inhibitors. Inspired by the efficacy of activity‐based probes for DUBs, several groups have recently reported probes for the ubiquitin conjugation machinery (E1, E2, and E3 enzymes). Many of these enzymes, while not proteases, also posses active site cysteine residues and can be targeted by covalent probes. In this review, we will discuss how features of the probe (cysteine‐reactive group, recognition element, and reporter tag) affect reactivity and suitability for certain experimental applications. We will also review the diverse applications of the current probes, and discuss the need for new probe types to study emerging aspects of ubiquitin biology.


Url:
DOI: 10.1111/febs.14039
PubMed: 28196299
PubMed Central: 7163952


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:7163952

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Activity‐based probes for the ubiquitin conjugation–deconjugation machinery: new chemistries, new tools, and new insights</title>
<author>
<name sortKey="Hewings, David S" sort="Hewings, David S" uniqKey="Hewings D" first="David S." last="Hewings">David S. Hewings</name>
<affiliation>
<nlm:aff id="febs14039-aff-0001"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="febs14039-aff-0002"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="febs14039-aff-0003"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="febs14039-aff-0004"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Flygare, John A" sort="Flygare, John A" uniqKey="Flygare J" first="John A." last="Flygare">John A. Flygare</name>
<affiliation>
<nlm:aff id="febs14039-aff-0001"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="febs14039-curr-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bogyo, Matthew" sort="Bogyo, Matthew" uniqKey="Bogyo M" first="Matthew" last="Bogyo">Matthew Bogyo</name>
<affiliation>
<nlm:aff id="febs14039-aff-0004"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Wertz, Ingrid E" sort="Wertz, Ingrid E" uniqKey="Wertz I" first="Ingrid E." last="Wertz">Ingrid E. Wertz</name>
<affiliation>
<nlm:aff id="febs14039-aff-0002"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="febs14039-aff-0003"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">28196299</idno>
<idno type="pmc">7163952</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163952</idno>
<idno type="RBID">PMC:7163952</idno>
<idno type="doi">10.1111/febs.14039</idno>
<date when="2017">2017</date>
<idno type="wicri:Area/Pmc/Corpus">000914</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000914</idno>
<idno type="wicri:Area/Pmc/Curation">000914</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000914</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000769</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000769</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Activity‐based probes for the ubiquitin conjugation–deconjugation machinery: new chemistries, new tools, and new insights</title>
<author>
<name sortKey="Hewings, David S" sort="Hewings, David S" uniqKey="Hewings D" first="David S." last="Hewings">David S. Hewings</name>
<affiliation>
<nlm:aff id="febs14039-aff-0001"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="febs14039-aff-0002"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="febs14039-aff-0003"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="febs14039-aff-0004"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Flygare, John A" sort="Flygare, John A" uniqKey="Flygare J" first="John A." last="Flygare">John A. Flygare</name>
<affiliation>
<nlm:aff id="febs14039-aff-0001"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="febs14039-curr-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bogyo, Matthew" sort="Bogyo, Matthew" uniqKey="Bogyo M" first="Matthew" last="Bogyo">Matthew Bogyo</name>
<affiliation>
<nlm:aff id="febs14039-aff-0004"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Wertz, Ingrid E" sort="Wertz, Ingrid E" uniqKey="Wertz I" first="Ingrid E." last="Wertz">Ingrid E. Wertz</name>
<affiliation>
<nlm:aff id="febs14039-aff-0002"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="febs14039-aff-0003"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Febs Journal</title>
<idno type="ISSN">1742-464X</idno>
<idno type="eISSN">1742-4658</idno>
<imprint>
<date when="2017">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>The reversible post‐translational modification of proteins by ubiquitin and ubiquitin‐like proteins regulates almost all cellular processes, by affecting protein degradation, localization, and complex formation. Deubiquitinases (
<styled-content style="fixed-case" toggle="no">DUB</styled-content>
s) are proteases that remove ubiquitin modifications or cleave ubiquitin chains. Most
<styled-content style="fixed-case" toggle="no">DUB</styled-content>
s are cysteine proteases, which makes them well suited for study by activity‐based probes. These
<styled-content style="fixed-case" toggle="no">DUB</styled-content>
probes report on deubiquitinase activity by reacting covalently with the active site in an enzyme‐catalyzed manner. They have proven to be important tools to study
<styled-content style="fixed-case" toggle="no">DUB</styled-content>
selectivity and proteolytic activity in different settings, to identify novel
<styled-content style="fixed-case" toggle="no">DUB</styled-content>
s, and to characterize deubiquitinase inhibitors. Inspired by the efficacy of activity‐based probes for
<styled-content style="fixed-case" toggle="no">DUB</styled-content>
s, several groups have recently reported probes for the ubiquitin conjugation machinery (E1, E2, and E3 enzymes). Many of these enzymes, while not proteases, also posses active site cysteine residues and can be targeted by covalent probes. In this review, we will discuss how features of the probe (cysteine‐reactive group, recognition element, and reporter tag) affect reactivity and suitability for certain experimental applications. We will also review the diverse applications of the current probes, and discuss the need for new probe types to study emerging aspects of ubiquitin biology.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lawton, G" uniqKey="Lawton G">G Lawton</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="review-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">FEBS J</journal-id>
<journal-id journal-id-type="iso-abbrev">FEBS J</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1742-4658</journal-id>
<journal-id journal-id-type="publisher-id">FEBS</journal-id>
<journal-title-group>
<journal-title>The Febs Journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">1742-464X</issn>
<issn pub-type="epub">1742-4658</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28196299</article-id>
<article-id pub-id-type="pmc">7163952</article-id>
<article-id pub-id-type="doi">10.1111/febs.14039</article-id>
<article-id pub-id-type="publisher-id">FEBS14039</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Special Issue: Proteases</subject>
<subj-group subj-group-type="heading">
<subject>Review Articles</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Activity‐based probes for the ubiquitin conjugation–deconjugation machinery: new chemistries, new tools, and new insights</article-title>
<alt-title alt-title-type="left-running-head">D. S. Hewings
<italic>et al</italic>
.</alt-title>
</title-group>
<contrib-group>
<contrib id="febs14039-cr-0001" contrib-type="author" corresp="yes">
<name>
<surname>Hewings</surname>
<given-names>David S.</given-names>
</name>
<contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9451-8959</contrib-id>
<xref ref-type="aff" rid="febs14039-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="febs14039-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="febs14039-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="febs14039-aff-0004">
<sup>4</sup>
</xref>
<address>
<email>hewingsd@gene.com</email>
</address>
</contrib>
<contrib id="febs14039-cr-0002" contrib-type="author">
<name>
<surname>Flygare</surname>
<given-names>John A.</given-names>
</name>
<xref ref-type="aff" rid="febs14039-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="febs14039-curr-0001">
<sup>5</sup>
</xref>
</contrib>
<contrib id="febs14039-cr-0003" contrib-type="author" corresp="yes">
<name>
<surname>Bogyo</surname>
<given-names>Matthew</given-names>
</name>
<xref ref-type="aff" rid="febs14039-aff-0004">
<sup>4</sup>
</xref>
<address>
<email>mbogyo@stanford.edu</email>
</address>
</contrib>
<contrib id="febs14039-cr-0004" contrib-type="author" corresp="yes">
<name>
<surname>Wertz</surname>
<given-names>Ingrid E.</given-names>
</name>
<xref ref-type="aff" rid="febs14039-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="febs14039-aff-0003">
<sup>3</sup>
</xref>
<address>
<email>ingrid@gene.com</email>
</address>
</contrib>
</contrib-group>
<aff id="febs14039-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Discovery Chemistry</named-content>
<institution>Genentech</institution>
<city>South San Francisco</city>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff>
<aff id="febs14039-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Early Discovery Biochemistry</named-content>
<institution>Genentech</institution>
<city>South San Francisco</city>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff>
<aff id="febs14039-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Discovery Oncology</named-content>
<institution>Genentech</institution>
<city>South San Francisco</city>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff>
<aff id="febs14039-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Pathology</named-content>
<institution>Stanford University School of Medicine</institution>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff>
<aff id="febs14039-curr-0001">
<label>
<sup>5</sup>
</label>
Present address:
<institution>Merck</institution>
<named-content content-type="street">630 Gateway Blvd</named-content>
<city>South San Francisco</city>
<named-content content-type="country-part">CA</named-content>
<postal-code>94080</postal-code>
<country country="US">USA</country>
</aff>
<author-notes>
<corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break></break>
D. S. Hewings, Discovery Chemistry, Genentech, South San Francisco, CA 94080, USA
<break></break>
Tel: +1 650 225 3652
<break></break>
E‐mail:
<email>hewingsd@gene.com</email>
<break></break>
and
<break></break>
I. E. Wertz, Discovery Oncology, Genentech, South San Francisco, CA 94080, USA
<break></break>
Tel: +1 650 225 6222
<break></break>
E‐mail:
<email>ingrid@gene.com</email>
<break></break>
and
<break></break>
M. Bogyo, Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
<break></break>
Fax: +1 650 725 7424
<break></break>
Tel: +1 650 725 4132
<break></break>
E‐mail:
<email>mbogyo@stanford.edu</email>
<break></break>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2017</year>
</pub-date>
<volume>284</volume>
<issue>10</issue>
<issue-id pub-id-type="doi">10.1111/febs.2017.284.issue-10</issue-id>
<issue-title content-type="special-issue-title">Proteases and Proteolysis in Health and Disease</issue-title>
<fpage>1555</fpage>
<lpage>1576</lpage>
<history>
<date date-type="received">
<day>09</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>21</day>
<month>1</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>2</month>
<year>2017</year>
</date>
</history>
<permissions>
<pmc-comment> Copyright © 2017 Federation of European Biochemical Societies </pmc-comment>
<copyright-statement content-type="article-copyright">© 2017 Federation of European Biochemical Societies</copyright-statement>
<license>
<license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:FEBS-284-1555.pdf"></self-uri>
<abstract id="febs14039-abs-0001">
<p>The reversible post‐translational modification of proteins by ubiquitin and ubiquitin‐like proteins regulates almost all cellular processes, by affecting protein degradation, localization, and complex formation. Deubiquitinases (
<styled-content style="fixed-case" toggle="no">DUB</styled-content>
s) are proteases that remove ubiquitin modifications or cleave ubiquitin chains. Most
<styled-content style="fixed-case" toggle="no">DUB</styled-content>
s are cysteine proteases, which makes them well suited for study by activity‐based probes. These
<styled-content style="fixed-case" toggle="no">DUB</styled-content>
probes report on deubiquitinase activity by reacting covalently with the active site in an enzyme‐catalyzed manner. They have proven to be important tools to study
<styled-content style="fixed-case" toggle="no">DUB</styled-content>
selectivity and proteolytic activity in different settings, to identify novel
<styled-content style="fixed-case" toggle="no">DUB</styled-content>
s, and to characterize deubiquitinase inhibitors. Inspired by the efficacy of activity‐based probes for
<styled-content style="fixed-case" toggle="no">DUB</styled-content>
s, several groups have recently reported probes for the ubiquitin conjugation machinery (E1, E2, and E3 enzymes). Many of these enzymes, while not proteases, also posses active site cysteine residues and can be targeted by covalent probes. In this review, we will discuss how features of the probe (cysteine‐reactive group, recognition element, and reporter tag) affect reactivity and suitability for certain experimental applications. We will also review the diverse applications of the current probes, and discuss the need for new probe types to study emerging aspects of ubiquitin biology.</p>
</abstract>
<abstract abstract-type="graphical" id="febs14039-abs-0002">
<p>E1, E2, E3, and deubiquitinating enzymes regulate protein ubiquitination, with profound consequences for protein stability and function. Therefore, there is considerable interest in developing approaches to study their activity. Activity‐based probes are valuable tools to understand the biochemical mechanisms and cellular functions of these enzymes.
<boxed-text position="anchor" content-type="graphic" id="febs14039-blkfxd-0001" orientation="portrait">
<graphic xlink:href="FEBS-284-1555-g029.jpg" position="anchor" id="nlm-graphic-1" orientation="portrait"></graphic>
</boxed-text>
</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="febs14039-kwd-0001">activity‐based probe</kwd>
<kwd id="febs14039-kwd-0002">activity‐based protein profiling</kwd>
<kwd id="febs14039-kwd-0003">chemoproteomics</kwd>
<kwd id="febs14039-kwd-0004">deubiquitinase</kwd>
<kwd id="febs14039-kwd-0005">E1</kwd>
<kwd id="febs14039-kwd-0006">E3</kwd>
<kwd id="febs14039-kwd-0007">protease</kwd>
<kwd id="febs14039-kwd-0008">ubiquitin</kwd>
<kwd id="febs14039-kwd-0009">ubiquitin–proteasome system</kwd>
</kwd-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="2"></table-count>
<page-count count="22"></page-count>
<word-count count="13428"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>May 2017</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.0 mode:remove_FC converted:15.04.2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</pmc>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Bogyo, Matthew" sort="Bogyo, Matthew" uniqKey="Bogyo M" first="Matthew" last="Bogyo">Matthew Bogyo</name>
<name sortKey="Flygare, John A" sort="Flygare, John A" uniqKey="Flygare J" first="John A." last="Flygare">John A. Flygare</name>
<name sortKey="Hewings, David S" sort="Hewings, David S" uniqKey="Hewings D" first="David S." last="Hewings">David S. Hewings</name>
<name sortKey="Wertz, Ingrid E" sort="Wertz, Ingrid E" uniqKey="Wertz I" first="Ingrid E." last="Wertz">Ingrid E. Wertz</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000769 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000769 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    RBID
   |clé=     PMC:7163952
   |texte=   Activity‐based probes for the ubiquitin conjugation–deconjugation machinery: new chemistries, new tools, and new insights
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i   -Sk "pubmed:28196299" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021